2.796
price down icon7.78%   -0.224
 
loading

Finanzdaten der Rezolute Inc-Aktie (RZLT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
22.22%
24.22
19.82 25.85 20.02 17.08
Depreciation and Amortization
12.50%
0.007
0.008 0.008 0.007 0.008
Operating Income/Loss
22.22%
-24.22
-19.82 -25.85 -20.02 -17.08
Nonoperating Income/Loss
13.20%
1.447
1.667 1.46 1.109 1.35
Income/Loss From Continuing Operations Before Tax
25.48%
-22.77
-18.15 -24.39 -18.91 -15.73
Income/Loss From Continuing Operations After Tax
25.48%
-22.77
-18.15 -24.39 -18.91 -15.73
Net Income/Loss
25.48%
-22.77
-18.15 -24.39 -18.91 -15.73
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.26%
103.69
103.42 6.0977 70.03 69.94
Diluted Average Shares
0.26%
103.69
103.42 6.0977 70.03 69.94
Basic Earnings Per Share
22.22%
-0.22
-0.18 -0.26 -0.27 -0.22
Diluted Earnings Per Share
22.22%
-0.22
-0.18 -0.26 -0.27 -0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):